juLY 8, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras
In this Q&A, Suh discusses what drew him to Inocras, why whole-genome analysis is approaching an inflection point, how Inocras is building the evidence base for broader clinical adoption, and what it will take for whole-genome-based care to become the new standard in oncology and rare disease. More

Press Releases

Our Newest Location: Mispro San Diego!
Reserve your space today in our Sorrento Mesa
Contract Vivarium
Learn More  →
  • Bifrost Biosystems: Pens Agreement With Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform More
  • CliniComp: FDA Clears PACS Viewer (MIMPS), Unifying Diagnostic Imaging, Enterprise EHR, and Native AI in a Single Platform More
  • Oncotelic: Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway More
One part for your entire Vivarium. Research ready from day one. Inno vive - Wash-free IVC racks and irradiated, pre-bedded caging that require zero prep time. Inno Vivarium Solutions - Flexible in vivo staffing, management and technical services built to scale with your needs. Contact us >

Financial News

Investment Banking Advisory to the Life Science Industry
Learn More  →
  • BioPharmCatalyst Weekly Watchlist: Key PDUFA and regulatory catalysts for the next 6 months More
  • More on Vertex’s $10B Crinetics Deal Marking Its Clearest Step Yet Toward Biopharma’s Top Ranks More* More More More
  • Resmed: Agreement to Sell MatrixCare Business More

Media/Misc Coverage

Biotech’s most flexible vivarium lab space to launch and scale studies.
Learn More  →
  • A Decade on the Map: How Big4Bio’s Regions Moved in GEN’s Top 10 Biopharma Clusters, 2016–2026 More
  • Big4Bio CEO Weekly Q&A: Jehee Suh, CEO, Inocras More
  • Germline‑Targeting HIV Vaccine Generates Broadly Neutralizing Antibodies in Primates More
  • Subscribe to LifeSci Startup for Updates on US Startups More
  • ZoBio: Expert Q&A More

Career Moves

slone
Life Sciences Talent and Consulting Strategist George Quinn Named Partner, Fractional Talent at Slone Partners
Learn More  →
  • ARS Pharmaceuticals: CEO Succession More
  • ICYMI: A View from the Trenches - Biotech Series A in 2026 More
  • ICYMI: Biotechs 'In Better Position to Avoid Workforce Reductions' as Layoffs Continue to Ease in Q2'26 More
  • ICYMI: Fierce Biotech Layoff Tracker 2026: BioCryst Ends Internal Programs; Biogen Sheds Apellis R&D Roles More
  • OPPORTUNITY: Chief Executive Officer, Cambridge, MA More
  • OPPORTUNITY: Chief Financial Officer, Pine Brook, NJ / Hybrid More
  • OPPORTUNITY: Vice President, Global BD, Remote More
  • Slone Partners: How to De-Risk Executive Hiring Decisions in Life Sciences and Healthcare More

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: BioFuture Oct 27-28
Learn More  →
  • Global Biotech CEO Summit July 13-15
  • ADLM Annual Meeting July 26-30
  • Biocom Seattle Summer Soirée Aug 5
  • Biocom San Diego Summer Soirée Aug 6
  • The Bioprocessing Summit 2026 Aug 10-13
  • Biocom Peninsula Summer Soirée Aug 13
  • Biocom East Bay Summer Soirée Aug 20

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: San Diego Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

San Diego Sponsors

Biocom Logo


Follow us

Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:San Diego, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.